Speaker Profile

___	__
	Biography Dr. Leyland is a Professor of OB/GYN at McMaster University. He has completed his Master of Science in Health Care Management from the Harvard School of Public Health.He is the immediate past Chair of the University Department of OB/GYN at McMaster University. Prior to this position he was the Medical Director of the Women's, Children's and Family Health Program and Chief of OB/GYN at the St. Joseph's Health Centre, University of Toronto.Dr. Leyland is the Director of a comprehensive research and clinical fellowship program in Advanced Gynecologic and Minimally Invasive Surgery.His clinical, educational and research interests revolve around the provision of and the improvement of access to minimally invasive reproductive surgical options for women. Disclosure 1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: a) Direct financial payments including receipt of honoraria: AbbVie, Baxter, Tersera. b) Membership on advisory boards or speakers’ bureaus: AbbVie, Baxter, Allergan. c) Funded grants or clinical trials: AbbVie. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Leyland is a Professor of OB/GYN at McMaster University. He has completed his Master of Science in Health Care Management from the Harvard School of Public Health.He is the immediate past Chair of the University Department of OB/GYN at McMaster University. Prior to this position he was the Medical Director of the Women's, Children's and Family Health Program and Chief of OB/GYN at the St. Joseph's Health Centre, University of Toronto.Dr. Leyland is the Director of a comprehensive research and clinical fellowship program in Advanced Gynecologic and Minimally Invasive Surgery.His clinical, educational and research interests revolve around the provision of and the improvement of access to minimally invasive reproductive surgical options for women.
Disclosure
1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: a) Direct financial payments including receipt of honoraria: AbbVie, Baxter, Tersera. b) Membership on advisory boards or speakers’ bureaus: AbbVie, Baxter, Allergan. c) Funded grants or clinical trials: AbbVie. 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).